PulseAugur
EN
LIVE 09:02:23
中文(ZH) 百诚医药：公司股票自2026年5月27日开市起继续停牌，预计继续停牌时间不超过3个交易日

Baicheng Pharma stock suspension extended; OKE Tech sets share price

By PulseAugur Editorial · [1 sources] ·

Baicheng Pharmaceutical announced that its stock will remain suspended from trading starting May 27, 2026, for an additional three trading days. This extension is due to ongoing negotiations concerning a change in the company's controlling shareholder. Separately, OKE Technology has set its inquiry-based transfer price at 96.45 yuan per share, with 65 institutional investors participating in the offering. AI

RANK_REASON The cluster contains multiple unrelated news items, including a stock suspension and a pricing announcement, without a unifying theme or significant AI angle.

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Baicheng Pharmaceutical: The company's stock will continue to be suspended from trading starting from the opening of the market on May 27, 2026, with an expected suspension period not exceeding 3 trading days.

    36氪获悉，百诚医药公告，因控股股东、实际控制人正在筹划涉及公司控制权变更的重大事项，公司股票自2026年5月25日开市起停牌，预计停牌时间不超过2个交易日。由于相关各方正在积极推进上述事项的工作，公司预计无法在2026年5月27日开市起复牌。根据深圳证券交易所的相关规定，经公司向深圳证券交易所申请，公司股票将于2026年5月27日开市起继续停牌，预计继续停牌时间不超过3个交易日。

RELATED TOPICS